BIOCELTIXBIOCELTIXBIOCELTIX

BIOCELTIX

No trades
See on Supercharts
Market capitalization
‪422.52 M‬PLN
−3.7PLN
‪−13.69 M‬PLN
0.00PLN
‪4.45 M‬
Beta (1Y)
−0.14
Employees (FY)
28
Revenue / Employee (1Y)
0.00PLN
Net income / Employee (1Y)
‪−488.84 K‬PLN

About BIOCELTIX


CEO
Lukasz Piotr Bzdzion
Headquarters
Wroclaw
Founded
2018
ISIN
PLBCLTX00019
FIGI
BBG013DQ9F61
Bioceltix SA engages in the research and development in the area of veterinary medicine. It develops stem cell therapy for animal use. The company was founded on August 13, 2018 and is headquartered in Wroclaw, Poland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BCX is 90.6 PLN — it has increased by 2.75% in the past 24 hours. Watch BIOCELTIX stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange BIOCELTIX stocks are traded under the ticker BCX.
BCX stock has risen by 11.43% compared to the previous week, the month change is a 14.71% rise, over the last year BIOCELTIX has showed a −1.09% decrease.
We've gathered analysts' opinions on BIOCELTIX future price: according to them, BCX price has a max estimate of 110.00 PLN and a min estimate of 110.00 PLN. Watch BCX chart and read a more detailed BIOCELTIX stock forecast: see what analysts think of BIOCELTIX and suggest that you do with its stocks.
BCX reached its all-time high on Jan 9, 2024 with the price of 98.0 PLN, and its all-time low was 28.7 PLN and was reached on Nov 8, 2022. View more price dynamics on BCX chart.
See other stocks reaching their highest and lowest prices.
BCX stock is 5.63% volatile and has beta coefficient of −0.14. Track BIOCELTIX stock price on the chart and check out the list of the most volatile stocks — is BIOCELTIX there?
Today BIOCELTIX has the market capitalization of ‪422.52 M‬, it has increased by 11.86% over the last week.
Yes, you can track BIOCELTIX financials in yearly and quarterly reports right on TradingView.
BCX net income for the last quarter is ‪−3.45 M‬ PLN, while the quarter before that showed ‪−4.23 M‬ PLN of net income which accounts for 18.38% change. Track more BIOCELTIX financial stats to get the full picture.
No, BCX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 28.00 employees. See our rating of the largest employees — is BIOCELTIX on this list?
Like other stocks, BCX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOCELTIX stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOCELTIX technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOCELTIX stock shows the strong buy signal. See more of BIOCELTIX technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.